Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer
Clinical trial NCT00467012 · COMPLETED
Trial details
- NCT number
- NCT00467012
- Sponsor
- Chugai Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2009-06-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.